EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis

Maj Jožef iD, Igor Locatelli, Gregor Brecl Jakob iD, Lina Savšek iD, Katarina Šurlan Popovič, Žiga Špiclin iD, Uroš Rot, Mitja Kos iD

PLOS ONE · 04.03.2024 · 19 (3) · e0294116

DOI: 10.1371/journal.pone.0294116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 04.03.2024. Verfasst von Maj Jožef und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Social Pharmacy, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Javna Agencija za Raziskovalno Dejavnost RS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 5-item Medication Adherence Report Scale (MARS-5) is a reliable and valid questionnaire for evaluating adherence in patients with asthma, hypertension, and diabetes. Validity has not been determined in multiple sclerosis (MS). We aimed to establish criterion validity and reliability of the MARS-5 in persons with MS (PwMS). Our prospective study included PwMS on dimethyl fumarate (DMF). PwMS self-completed the MARS-5 on the same day before baseline and follow-up brain magnetic resonance imaging (MRI) 3 and 9 months after treatment initiation and were graded as highly and medium adherent upon the 24-cut-off score, established by receiver operator curve analysis. Health outcomes were represented by relapse occurrence from the 1 st DMF dispense till follow-up brain MRI and radiological progression (new T2 MRI lesions and quantitative analysis) between baseline and follow-up MRI. Criterion validity was established by association with the Proportion of Days Covered (PDC), new T2 MRI lesions, and Beliefs in Medicines questionnaire (BMQ). The reliability evaluation included internal consistency and the test-retest method. We included 40 PwMS (age 37.6 ± 9.9 years, 75% women), 34 were treatment-naive. No relapses were seen during the follow-up period but quantitative MRI analysis showed new T2 lesions in 6 PwMS. The mean (SD) MARS-5 score was 23.1 (2.5), with 24 PwMS graded as highly adherent. The higher MARS-5 score was associated with higher PDC (b = 0.027, P< 0.001, 95% CI: (0.0134–0.0403)) and lower medication concerns (b = -1.25, P< 0.001, 95% CI: (-1.93-(-0,579)). Lower adherence was associated with increased number ( P = 0.00148) and total volume of new T2 MRI lesions ( P = 0.00149). The questionnaire showed acceptable internal consistency (Cronbach α = 0.72) and moderate test-retest reliability ( r = 0.62, P < 0.0001, 95% CI: 0.33–0.79). The MARS-5 was found to be valid and reliable for estimating medication adherence and predicting medication concerns in persons with MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansFemaleAdultMiddle AgedMaleProspective StudiesPsychometricsReproducibility of ResultsDimethyl FumarateMedication Adherence

Substanzen

Dimethyl Fumarate

Autor:innen und Institutionen

  • Chair of Social Pharmacy, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Multiple Sclerosis Centre, Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Department of Neurology, General Hospital Celje, Celje, Slovenia.
  • Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Laboratory for Imaging Technologies, Faculty of Electrical Engineering, University of Ljubljana, Ljubljana, Slovenia.
  • Chair of Neurology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Maj Jožef, Gregor Brecl Jakob, Lina Savšek, Žiga Špiclin, Mitja Kos

Förderung

  • Javna Agencija za Raziskovalno Dejavnost RS

Zitieren

APA

Jožef, M., Locatelli, I., Brecl Jakob, G., Savšek, L., Šurlan Popovič, K., Špiclin, Ž., Rot, U., & Kos, M. (2024). Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis. PLOS ONE, 19(3), e0294116. https://doi.org/10.1371/journal.pone.0294116

Vancouver

Jožef M, Locatelli I, Brecl Jakob G, Savšek L, Šurlan Popovič K, Špiclin Ž, et al. Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis. PLOS ONE. 2024;19(3):e0294116. doi:10.1371/journal.pone.0294116

BibTeX
@article{Joef2024,
  author = {Jožef, Maj and Locatelli, Igor and Brecl Jakob, Gregor and Savšek, Lina and Šurlan Popovič, Katarina and Špiclin, Žiga and Rot, Uroš and Kos, Mitja},
  title = {Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {3},
  pages = {e0294116},
  doi = {10.1371/journal.pone.0294116}
}
Kostenlos starten →